{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:38:45Z","timestamp":1784709525953,"version":"3.55.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-022-00836-x","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T13:10:22Z","timestamp":1653397822000},"page":"679-688","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties"],"prefix":"10.1007","volume":"23","author":[{"given":"Hayder M.","family":"Al-kuraishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6503-0719","authenticated-orcid":false,"given":"Maisra M.","family":"El-Bouseary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma I.","family":"Sonbol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"key":"836_CR1","unstructured":"Rogers AP, Estes M. Hyperviscosity syndrome. StatPearls[internet]; 2021Jul21."},{"issue":"2","key":"836_CR2","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1016\/S2352-3026(19)30210-8","volume":"7","author":"RG Owen","year":"2020","unstructured":"Owen RG, McCarthy H, Rule S, d\u2019Sa S, et al. Acalabrutinib monotherapy in patients with Waldenstr\u00f6mmacroglobulinemia: a single-arm, multicentre, phase 2 study. Lancet Haematol. 2020;7(2):e112\u201321. https:\/\/doi.org\/10.1016\/S2352-3026(19)30210-8.","journal-title":"Lancet Haematol"},{"issue":"10","key":"836_CR3","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1182\/blood-2011-04-347690","volume":"119","author":"MJ Stone","year":"2012","unstructured":"Stone MJ, Bogen SA. Evidence-based focused review of management of hyperviscosity syndrome. Blood. 2012;119(10):2205\u20138. https:\/\/doi.org\/10.1182\/blood-2011-04-347690.","journal-title":"Blood"},{"key":"836_CR4","unstructured":"Bekelman J, Jackson N, Donehower R.\u00a0Oncologic emergencies.\u00a02nd\u00a0ed. Philadelphia: Saunders Elsevier; 2006."},{"key":"836_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/10760296211020833","author":"B Joob","year":"2021","unstructured":"Joob B, Wiwanitkit V. Expected viscosityafter COVID-19 vaccination, hyperviscosity and previous COVID-19. Clin ApplThromb Hemost. 2021. https:\/\/doi.org\/10.1177\/10760296211020833.","journal-title":"Clin ApplThromb Hemost"},{"issue":"11","key":"836_CR6","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.amjmed.2004.09.011","volume":"117","author":"L Garderet","year":"2004","unstructured":"Garderet L, Fabiani B, Lacombe K, Girard PM, Fl\u00e9jou JF, Gorin NC. Hyperviscosity syndrome in an HIV-1\u2014positive patient. Am J Med. 2004;117(11):891\u20133. https:\/\/doi.org\/10.1016\/j.amjmed.2004.09.011.","journal-title":"Am J Med"},{"issue":"6","key":"836_CR7","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1182\/blood-2003-07-2375","volume":"103","author":"A De Milito","year":"2004","unstructured":"De Milito A, Nilsson A, Titanji K, et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood. 2004;103(6):2180\u20136. https:\/\/doi.org\/10.1182\/blood-2003-07-2375.","journal-title":"Blood"},{"issue":"3","key":"836_CR8","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/1096-8652(200007)64:3<210::aid-ajh13>3.0.co;2-#","volume":"64","author":"DK Jin","year":"2000","unstructured":"Jin DK, Nowakowski M, Kramer M, Essex DW. Hyperviscosity syndrome secondary to a myeloma-associated IgG1\u03baparaprotein strongly reactive against the HIV-1 p24 gag antigen. AmJ Hematol. 2000;64(3):210\u20133. https:\/\/doi.org\/10.1002\/1096-8652(200007)64:3%3c210::aid-ajh13%3e3.0.co;2-#.","journal-title":"AmJ Hematol"},{"issue":"3","key":"836_CR9","first-page":"44","volume":"74","author":"BP Bogomolov","year":"2002","unstructured":"Bogomolov BP, Deviatkin AV. Microcirculation and hemostasis in influenza and acute viral respiratory infections complicated with pneumonia. Ter Arkh. 2002;74(3):44\u20138.","journal-title":"Ter Arkh"},{"issue":"2","key":"836_CR10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7090","volume":"12","author":"GD Sloop","year":"2020","unstructured":"Sloop GD, De Mast Q, Pop G, Weidman JJ, St Cyr JA. The role of blood viscosity in infectious diseases. Cureus. 2020;12(2): e7090. https:\/\/doi.org\/10.7759\/cureus.7090.","journal-title":"Cureus"},{"issue":"4","key":"836_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000151636","volume":"26","author":"G Pi\u00f1ol-Ripoll","year":"2008","unstructured":"Pi\u00f1ol-Ripoll G, De La Puerta I, Santos S, Purroy F, Mostacero E. Chronic bronchitis and acute infections as new risk factors for ischemic stroke and the lack of protection offered by the influenza vaccination. CerebrovascDis. 2008;26(4):339\u201347. https:\/\/doi.org\/10.1159\/000151636.","journal-title":"CerebrovascDis"},{"key":"836_CR12","unstructured":"Yang Y, Wang K, Han LY, Li XH, Wang HM. Hemorheologic changes in patients with chronic hepatitis B.Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005;19(1):61\u20133."},{"issue":"3","key":"836_CR13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2141.1979.tb01155.x","volume":"42","author":"SG Richardson","year":"1979","unstructured":"Richardson SG, Matthews KB, Cruickshank JK, Geddes AM, Stuart J. Coagulation activation and hyperviscosity in infection. BrJ Haematol. 1979;42(3):469\u201380. https:\/\/doi.org\/10.1111\/j.1365-2141.1979.tb01155.x.","journal-title":"BrJ Haematol"},{"issue":"1","key":"836_CR14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/s12879-018-3473-2","volume":"18","author":"H Van Tong","year":"2018","unstructured":"Van Tong H, Van Ba N, Hoan NX, et al. Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases. BMC Infect Dis. 2018;18(1):553. https:\/\/doi.org\/10.1186\/s12879-018-3473-2.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"836_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.4297\/najms.2010.2353","volume":"2","author":"EU Nwose","year":"2010","unstructured":"Nwose EU. Whole blood viscosity assessment issues IV: Prevalence in acute phase inflammation. North Am J Med Sci. 2010;2(8):353\u20138. https:\/\/doi.org\/10.4297\/najms.2010.2353.","journal-title":"North Am J Med Sci"},{"issue":"5","key":"836_CR16","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3899\/jrheum.200591","volume":"48","author":"JB Miller","year":"2021","unstructured":"Miller JB, Baer AN. Hyperviscosity syndrome in rheumatoid arthritis. J Rheumatol. 2021;48(5):788\u20139. https:\/\/doi.org\/10.3899\/jrheum.200591.","journal-title":"J Rheumatol"},{"issue":"5","key":"836_CR17","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/bjh.14743","volume":"177","author":"JN Gustine","year":"2017","unstructured":"Gustine JN, Meid K, Dubeau T, et al. Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenstr\u00f6mmacroglobulinaemia. Br J Haematol. 2017;177(5):717\u201325. https:\/\/doi.org\/10.1111\/bjh.14743.","journal-title":"Br J Haematol"},{"issue":"2","key":"836_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.transci.2018.02.004","volume":"57","author":"PM Lokhandwala","year":"2018","unstructured":"Lokhandwala PM, Shabihkhani M, Ness PM, Bloch EM. Therapeutic plasma exchange for hyperviscosity syndrome secondary to high rheumatoid factor. Transfus ApherSci. 2018;57(2):225\u20137. https:\/\/doi.org\/10.1016\/j.transci.2018.02.004.","journal-title":"Transfus ApherSci"},{"issue":"6","key":"836_CR19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.7326\/0003-4819-153-6-201009210-00023","volume":"153","author":"FE CorriganIII","year":"2010","unstructured":"CorriganIII FE, Leventhal AR, Khan S, Rao S, Christopher-Stine L, Schulman SP. A rare cause of cardiac ischemia: systemic lupus erythematosus presenting as the hyperviscosity syndrome. Ann Intern Med. 2010;153(6):422\u20134. https:\/\/doi.org\/10.7326\/0003-4819-153-6-201009210-00023.","journal-title":"Ann Intern Med"},{"issue":"4","key":"836_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/ccr3.201","volume":"3","author":"LY Chen","year":"2015","unstructured":"Chen LY, Wong PC, Noda S, Collins DR, Sreenivasan GM, Coupland RC. Polyclonal hyperviscosity syndrome in IgG4-related disease and associated conditions. Clin Case Rep. 2015;3(4):217\u201326. https:\/\/doi.org\/10.1002\/ccr3.201.","journal-title":"Clin Case Rep"},{"issue":"4","key":"836_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm.3057","volume":"19","author":"A Chow","year":"2013","unstructured":"Chow A, Huggins M, Ahmed J, et al. CD169+ macrophages provide a niche promoting erythropoiesis under homeostasis and stress. Nat Med. 2013;19(4):429\u201336. https:\/\/doi.org\/10.1038\/nm.3057.","journal-title":"Nat Med"},{"issue":"2","key":"836_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/jb\/mvy050","volume":"164","author":"K Asano","year":"2018","unstructured":"Asano K, Kikuchi K, Tanaka M. CD169 macrophages regulate immune responses toward particulate materials in the circulating fluid. J Biochem. 2018;164(2):77\u201385. https:\/\/doi.org\/10.1093\/jb\/mvy050.","journal-title":"J Biochem"},{"issue":"2","key":"836_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3892\/br.2020.1402","volume":"14","author":"Y Liu","year":"2021","unstructured":"Liu Y, Xia Y, Qiu CH. Functions of CD169 positive macrophages in human diseases (Review). Biomed Rep. 2021;14(2):26.","journal-title":"Biomed Rep"},{"issue":"3","key":"836_CR24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/vaccines8030380","volume":"8","author":"HF Hetta","year":"2020","unstructured":"Hetta HF, Mekky MA, Zahran AM, et al. Regulatory B cells and their cytokine profile in HCV-related hepatocellular carcinoma: association with regulatory T cells and disease progression. Vaccines. 2020;8(3):380. https:\/\/doi.org\/10.3390\/vaccines8030380.","journal-title":"Vaccines"},{"issue":"2","key":"836_CR25","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/vaccines8020340","volume":"8","author":"HF Hetta","year":"2020","unstructured":"Hetta HF, Mwafey IM, Batiha GE, et al. CD19+ CD24hi CD38hi regulatory B cells and memory B cells in periodontitis: association with pro-inflammatory and anti-inflammatory cytokines. Vaccines. 2020;8(2):340. https:\/\/doi.org\/10.3390\/vaccines8020340.","journal-title":"Vaccines"},{"issue":"6","key":"836_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1515\/arh-2003-0020","volume":"13","author":"GAM Pop","year":"2003","unstructured":"Pop GAM, Hop WJ, Moraru L, et al. Blood electrical impedance closely matches whole blood viscosity as parameter of hemorheology and inflammation. Appl Rheol. 2003;13(6):305\u201312. https:\/\/doi.org\/10.1515\/arh-2003-0020.","journal-title":"Appl Rheol"},{"issue":"1","key":"836_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.fsi.2015.03.005","volume":"46","author":"MA Gordy","year":"2015","unstructured":"Gordy MA, Pila EA, Hanington PC. The role of fibrinogen-related proteins in the gastropod immune response. Fish Shellfish Immunol. 2015;46(1):39\u201349. https:\/\/doi.org\/10.1016\/j.fsi.2015.03.005.","journal-title":"Fish Shellfish Immunol"},{"issue":"5","key":"836_CR28","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1160\/TH12-10-0739","volume":"109","author":"LI P\u00e5hlman","year":"2013","unstructured":"P\u00e5hlman LI, M\u00f6rgelin M, Kasetty G, Olin AI, Schmidtchen A, Herwald H. Antimicrobial activity of fibrinogen and fibrinogen-derived peptides\u2013a novel link between coagulation and innate immunity. Thromb Haemost. 2013;109(5):930\u20139. https:\/\/doi.org\/10.1160\/TH12-10-0739.","journal-title":"Thromb Haemost"},{"issue":"11","key":"836_CR29","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1007\/s11010-021-04232-z","volume":"476","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ, Cruz-Martins N, Batiha GE. The potential role of neopterin in Covid-19: a new perspective. Mol Cell Biochem. 2021;476(11):4161\u20136. https:\/\/doi.org\/10.1007\/s11010-021-04232-z.","journal-title":"Mol Cell Biochem"},{"issue":"12","key":"836_CR30","doi-asserted-by":"publisher","first-page":"8195","DOI":"10.1007\/s11033-021-06770-7","volume":"48","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ, Alexiou A, Batiha GE. Niclosamide for Covid-19: bridging the gap. MolBiolRep. 2021;48(12):8195\u2013202. https:\/\/doi.org\/10.1007\/s11033-021-06770-7.","journal-title":"MolBiolRep"},{"key":"836_CR31","doi-asserted-by":"publisher","first-page":"174196","DOI":"10.1016\/j.ejphar.2021.174196","volume":"904","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Almulaiky YQ, Cruz-Martins N, El-Saber Batiha GE. Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: the enigmatic entity. EurJ Pharmacol. 2021;904:174196. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174196.","journal-title":"EurJ Pharmacol"},{"issue":"10","key":"836_CR32","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1089\/vim.2021.0042","volume":"34","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alkazmi L, Alexiou A, Batiha GE. Levamisoletherapy in COVID-19. Viral Immunol. 2021;34(10):722\u20135. https:\/\/doi.org\/10.1089\/vim.2021.0042.","journal-title":"Viral Immunol"},{"key":"836_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.642822","volume":"12","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alqarni M, Cruz-Martins N, El-Saber BG. Pleiotropic effects of tetracyclines in the management of COVID-19: emergingperspectives. Front Pharmacol. 2021;12: 642822. https:\/\/doi.org\/10.3389\/fphar.2021.642822.","journal-title":"Front Pharmacol"},{"issue":"23","key":"836_CR34","doi-asserted-by":"publisher","first-page":"7565","DOI":"10.26355\/eurrev_202112_27456","volume":"25","author":"GE Batiha","year":"2021","unstructured":"Batiha GE, Shaheen HM, Al-Kuraishy HM, et al. Possible mechanistic insights into iron homeostasis role of the action of 4-aminoquinolines (chloroquine\/hydroxychloroquine) on COVID-19 (SARS-CoV-2) infection. Eur Rev Med Pharmacol Sci. 2021;25(23):7565\u201384. https:\/\/doi.org\/10.26355\/eurrev_202112_27456.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"836_CR35","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.clnesp.2021.12.030","volume":"47","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, El-Saber Batiha GE. The possible role of ursolic acid in Covid-19: a real game changer. Clin Nutr ESPEN. 2022;47:414\u20137. https:\/\/doi.org\/10.1016\/j.clnesp.2021.12.030.","journal-title":"Clin Nutr ESPEN"},{"key":"836_CR36","doi-asserted-by":"publisher","first-page":"649128","DOI":"10.3389\/fnut.2021.649128","volume":"8","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Faidah H, Al-Maiahy TJ, Cruz-Martins N, Batiha GE. The looming effects of estrogen in Covid-19: a rocky rollout. Front Nutr. 2021;8:649128. https:\/\/doi.org\/10.3389\/fnut.2021.649128.","journal-title":"Front Nutr"},{"issue":"4","key":"836_CR37","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1111\/bjh.17306","volume":"192","author":"C Renoux","year":"2021","unstructured":"Renoux C, Fort R, Nader E, et al. Impact of COVID-19 on red blood cell rheology. Br J Haematol. 2021;192(4):e108\u201311. https:\/\/doi.org\/10.1111\/bjh.17306.","journal-title":"Br J Haematol"},{"issue":"3","key":"836_CR38","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<373::AID-PATH593>3.0.CO;2-3","volume":"190","author":"HA Lehr","year":"2000","unstructured":"Lehr HA, Bittinger F, Kirkpatrick CJ. Microcirculatory dysfunction in sepsis: A pathogenetic basis for therapy? J Pathol. 2000;190(3):373\u201386.","journal-title":"J Pathol"},{"issue":"1","key":"836_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ccell.2010.12.004","volume":"23","author":"DJ Lundy","year":"2011","unstructured":"Lundy DJ, Trzeciak S. Microcirculatory dysfunction in sepsis. Crit Care Nurs Clin North Am. 2011;23(1):67\u201377. https:\/\/doi.org\/10.1016\/j.ccell.2010.12.004.","journal-title":"Crit Care Nurs Clin North Am"},{"issue":"11","key":"836_CR40","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3389\/fphys.2020.00747","volume":"26","author":"A Colantuoni","year":"2020","unstructured":"Colantuoni A, Martini R, Caprari P, et al. COVID-19 sepsis and microcirculation dysfunction. Front Physiol. 2020;26(11):747. https:\/\/doi.org\/10.3389\/fphys.2020.00747.","journal-title":"Front Physiol"},{"issue":"1","key":"836_CR41","first-page":"93","volume":"11","author":"B Joob","year":"2021","unstructured":"Joob B, Wiwanitkit V. Blood viscosity of COVID-19 patient: a preliminary report. Am J Blood Res. 2021;11(1):93\u20135.","journal-title":"Am J Blood Res"},{"issue":"4","key":"836_CR42","first-page":"129","volume":"63","author":"SK Klein","year":"2005","unstructured":"Klein SK, Slim EJ, De Kruif MD, et al. Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med. 2005;63(4):129\u201336.","journal-title":"Neth J Med"},{"issue":"21","key":"836_CR43","doi-asserted-by":"publisher","first-page":"8234","DOI":"10.3390\/ijms21218234","volume":"21","author":"C Venter","year":"2020","unstructured":"Venter C, Bezuidenhout JA, Laubscher GJ, et al. Erythrocyte, platelet, serum ferritin, and p-selectin pathophysiology implicated in severe hypercoagulation and vascular complications in COVID-19. Int J Mol Sci. 2020;21(21):8234. https:\/\/doi.org\/10.3390\/ijms21218234.","journal-title":"Int J Mol Sci"},{"key":"836_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112193","volume":"143","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Qusti S, Alshammari EM, Atanu FO, Batiha GE. Arginine vasopressin and pathophysiology of COVID-19: an innovative perspective. Biomed Pharmacother. 2021;143: 112193. https:\/\/doi.org\/10.1016\/j.biopha.2021.112193.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"836_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.13545","volume":"45","author":"HS Alamri","year":"2021","unstructured":"Alamri HS, Alsughayyir J, Akiel M, et al. Stimulation of calcium influx and CK1\u03b1 by NF-\u03baB antagonist [6]-gingerol reprograms red blood cell longevity. J Food Biochem. 2021;45(1): e13545. https:\/\/doi.org\/10.1111\/jfbc.13545.","journal-title":"J Food Biochem"},{"key":"836_CR46","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3389\/fimmu.2020.00454","volume":"11","author":"E Nader","year":"2020","unstructured":"Nader E, Romana M, Connes P. The red blood cell\u2014inflammation vicious circle in sickle cell disease. Front Immunol. 2020;11:454. https:\/\/doi.org\/10.3389\/fimmu.2020.00454.","journal-title":"Front Immunol"},{"key":"836_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.sciaf.2021.e01084","author":"GE Batiha","year":"2021","unstructured":"Batiha GE, Al-Gareeb DAI, Qusti S, et al. Common NLRP3 inflammasome inhibitors and Covid-19: divide and Conquer. Sci Afr. 2021. https:\/\/doi.org\/10.1016\/j.sciaf.2021.e01084.","journal-title":"Sci Afr"},{"issue":"4","key":"836_CR48","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/infdis\/jiaa724","volume":"223","author":"AS Bedin","year":"2021","unstructured":"Bedin AS, Makinson A, Picot MC, et al. Monocyte CD169 expression as a biomarker in the early diagnosis of coronavirus disease 2019. J Infect Dis. 2021;223(4):562\u20137. https:\/\/doi.org\/10.1093\/infdis\/jiaa724.","journal-title":"J Infect Dis"},{"key":"836_CR49","doi-asserted-by":"publisher","first-page":"108516","DOI":"10.1016\/j.intimp.2021.108516","volume":"104","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Al-Hussaniy HA, Al-Harcan NAH, Alexiou A, Batiha GE. Neutrophil extracellular traps (NETs) and Covid-19: a new frontiers for therapeutic modality. IntImmunopharmacol. 2022;104:108516. https:\/\/doi.org\/10.1016\/j.intimp.2021.108516.","journal-title":"IntImmunopharmacol"},{"issue":"7","key":"836_CR50","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/jth.14850","volume":"18","author":"M Panigada","year":"2020","unstructured":"Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18(7):1738\u201342. https:\/\/doi.org\/10.1111\/jth.14850.","journal-title":"J Thromb Haemost"},{"key":"836_CR51","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004967","author":"S Ozkan","year":"2021","unstructured":"Ozkan S, Cakmak F, Konukoglu D, et al. Efficacy of serumangiotensin IIlevels in prognosis of patients with coronavirus Disease 2019. Crit Care Med. 2021. https:\/\/doi.org\/10.1097\/CCM.0000000000004967.","journal-title":"Crit Care Med"},{"issue":"5","key":"836_CR52","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.3906\/sag-1609-33","volume":"47","author":"N Buyan","year":"2017","unstructured":"Buyan N, Ak\u00e7aboy M, G\u00f6kta\u015f T, et al. Effects of whole blood viscosity and plasma NOx on cardiac function and cerebral blood flow in children with chronic kidney disease. Turk J Med Sci. 2017;47(5):1482\u201391. https:\/\/doi.org\/10.3906\/sag-1609-33.","journal-title":"Turk J Med Sci"},{"issue":"3","key":"836_CR53","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1161\/CIRCRESAHA.120.317173","volume":"127","author":"F Violi","year":"2020","unstructured":"Violi F, Ceccarelli G, Cangemi R, et al. Hypoalbuminemia, coagulopathy, and vascular disease in COVID-19. Circ Res. 2020;127(3):400\u20131. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317173.","journal-title":"Circ Res"},{"issue":"5","key":"836_CR54","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1080\/09537104.2020.1760230","volume":"31","author":"X Bi","year":"2020","unstructured":"Bi X, Su Z, Yan H, et al. Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin ratio and Platelet count. Platelets. 2020;31(5):674\u20139. https:\/\/doi.org\/10.1080\/09537104.2020.1760230.","journal-title":"Platelets"},{"issue":"3","key":"836_CR55","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.tcm.2020.12.004","volume":"31","author":"MAM Ali","year":"2021","unstructured":"Ali MAM, Spinler SA. COVID-19 and thrombosis: from bench to bedside. Trends Cardiovasc Med. 2021;31(3):143\u201360. https:\/\/doi.org\/10.1016\/j.tcm.2020.12.004.","journal-title":"Trends Cardiovasc Med"},{"issue":"10234","key":"836_CR56","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(20)30937-5.","journal-title":"Lancet"},{"issue":"3","key":"836_CR57","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1109\/TNB.2020.2984880","volume":"19","author":"L Felicetti","year":"2020","unstructured":"Felicetti L, Femminella M, Reali G. A molecular communications system for live detection of hyperviscosity syndrome. IEEE Trans Nanobioscience. 2020;19(3):410\u201321. https:\/\/doi.org\/10.1109\/TNB.2020.2984880.","journal-title":"IEEE Trans Nanobioscience"},{"issue":"3","key":"836_CR58","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s12015-020-09976-7","volume":"16","author":"H Ulrich","year":"2020","unstructured":"Ulrich H, Pillat MM. CD147 as a target for COVID-19 treatment: suggested effects of azithromycin and stem cell engagement. Stem Cell Rev Rep. 2020;16(3):434\u201340. https:\/\/doi.org\/10.1007\/s12015-020-09976-7.","journal-title":"Stem Cell Rev Rep"},{"issue":"11","key":"836_CR59","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.3390\/app10114053","volume":"10","author":"I Cosic","year":"2020","unstructured":"Cosic I, Cosic D, Loncarevic I. RRM prediction of erythrocyte Band3 protein as alternative receptor for SARS-CoV-2 virus. Appl Sci. 2020;10(11):4053. https:\/\/doi.org\/10.3390\/app10114053.","journal-title":"Appl Sci"},{"key":"836_CR60","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.22058","author":"BH Foy","year":"2020","unstructured":"Foy BH, Carlson JCT, Reinertsen E, et al. Association of red blood cell distribution width with mortality risk in hospitalized adults with SARS-CoV-2 infection. JAMA Netw Open. 2020. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.22058.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"836_CR61","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/bjc.1993.134","volume":"67","author":"BD Kavanagh","year":"1993","unstructured":"Kavanagh BD, Coffey BE, Needham D, Hochmuth RM, Dewhirst MW. The effect of flunarizine on erythrocyte suspension viscosity under conditions of extreme hypoxia, low pH, and lactate treatment. BrJ Cancer. 1993;67(4):734\u201341. https:\/\/doi.org\/10.1038\/bjc.1993.134.","journal-title":"BrJ Cancer"},{"issue":"5","key":"836_CR62","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1042\/cs0920473","volume":"92","author":"GD Sloop","year":"1997","unstructured":"Sloop GD, Garber DW. The effects of low-density lipoprotein and high-density lipoprotein on blood viscosity correlate with their association with risk of atherosclerosis in humans. Clin Sci (Lond). 1997;92(5):473\u20139. https:\/\/doi.org\/10.1042\/cs0920473.","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"836_CR63","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.exphem.2005.07.004","volume":"33","author":"I Meurs","year":"2005","unstructured":"Meurs I, Hoekstra M, van Wanrooij EJ, et al. HDL cholesterol levels are an important factor for determining the lifespan of erythrocytes. Exp Hematol. 2005;33(11):1309\u201319. https:\/\/doi.org\/10.1016\/j.exphem.2005.07.004.","journal-title":"Exp Hematol"},{"issue":"9","key":"836_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239573","volume":"15","author":"S Tanaka","year":"2020","unstructured":"Tanaka S, De Tymowski C, Assadi M, et al. Lipoprotein concentrations over time in the intensive care unit COVID-19 patients: results from the ApoCOVID study. PLoS ONE. 2020;15(9): e0239573. https:\/\/doi.org\/10.1371\/journal.pone.0239573.","journal-title":"PLoS ONE"},{"key":"836_CR65","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cca.2020.07.015","volume":"510","author":"X Hu","year":"2020","unstructured":"Hu X, Chen D, Wu L, He G, Ye W. Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection. Clin Chim Acta. 2020;510:105\u201310. https:\/\/doi.org\/10.1016\/j.cca.2020.07.015.","journal-title":"Clin Chim Acta"},{"key":"836_CR66","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3389\/fphys.2020.605908","volume":"11","author":"R Chang","year":"2020","unstructured":"Chang R, Mamun A, Dominic A, Le NT. SARS-CoV-2 mediated endothelial dysfunction: the potential role of chronic oxidative stress. Front Physiol. 2020;11:1752. https:\/\/doi.org\/10.3389\/fphys.2020.605908.","journal-title":"Front Physiol"},{"issue":"11","key":"836_CR67","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1111\/jth.13482","volume":"14","author":"M Becatti","year":"2016","unstructured":"Becatti M, Marcucci R, Gori AM, et al. Erythrocyte oxidative stress is associated with cell deformability in patients with retinal vein occlusion. J Thromb Haemost. 2016;14(11):2287\u201397. https:\/\/doi.org\/10.1111\/jth.13482.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"836_CR68","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12890-020-01310-8","volume":"20","author":"E Mortaz","year":"2020","unstructured":"Mortaz E, Malkmohammad M, Jamaati H, et al. Silent hypoxia: higherNO in red blood cells of COVID-19 patients. BMC PulmMed. 2020;20(1):269. https:\/\/doi.org\/10.1186\/s12890-020-01310-8.","journal-title":"BMC PulmMed"},{"key":"836_CR69","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab724.3364","author":"A Mahdi","year":"2021","unstructured":"Mahdi A, Collado A, Tengbom J, et al. Erythrocytes induce vascular dysfunction in COVID-19. Eur Heart J. 2021. https:\/\/doi.org\/10.1093\/eurheartj\/ehab724.3364.","journal-title":"Eur Heart J"},{"issue":"1","key":"836_CR70","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41398-020-00913-3","volume":"10","author":"W Fu","year":"2020","unstructured":"Fu W, Wang C, Zou L, et al. Psychological health, sleep quality, and coping styles to stress facing the COVID-19 in Wuhan, China. Transl Psychiatry. 2020;10(1):225. https:\/\/doi.org\/10.1038\/s41398-020-00913-3.","journal-title":"Transl Psychiatry"},{"issue":"8","key":"836_CR71","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1111\/jch.13625","volume":"21","author":"JH Jeong","year":"2019","unstructured":"Jeong JH, Hanevold C, Harris RA, et al. Angiotensin II receptor blocker attenuates stress pressor response in young adult African Americans. J Clin Hypertens (Greenwich). 2019;21(8):1191\u20139. https:\/\/doi.org\/10.1111\/jch.13625.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"3","key":"836_CR72","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2217\/bmm-2019-0483","volume":"14","author":"B Tekin Tak","year":"2020","unstructured":"Tekin Tak B, Ekizler FA, Cay S, et al. Relationship between apical thrombus formation and blood viscosity in acute anterior myocardial infarction patients. Biomark Med. 2020;14(3):201\u201310. https:\/\/doi.org\/10.2217\/bmm-2019-0483.","journal-title":"Biomark Med"},{"issue":"1","key":"836_CR73","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12883-019-1315-5","volume":"19","author":"CH Lee","year":"2019","unstructured":"Lee CH, Jung KH, Cho DJ, Jeong SK. Effect of warfarin versus aspirin on blood viscosity in cardioembolic stroke with atrial fibrillation: a prospective clinical trial. BMC Neurol. 2019;19(1):82. https:\/\/doi.org\/10.1186\/s12883-019-1315-5.","journal-title":"BMC Neurol"},{"issue":"5","key":"836_CR74","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jacc.2020.06.007","volume":"76","author":"A Lala","year":"2020","unstructured":"Lala A, Johnson KW, Januzzi JL, et al. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol. 2020;76(5):533\u201346. https:\/\/doi.org\/10.1016\/j.jacc.2020.06.007.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"836_CR75","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/trf.16218","volume":"61","author":"AD Truong","year":"2021","unstructured":"Truong AD, Auld SC, Barker NA, et al. Therapeutic plasma exchange for COVID-19-associated hyperviscosity. Transfusion. 2021;61(4):1029\u201334. https:\/\/doi.org\/10.1111\/trf.16218.","journal-title":"Transfusion"},{"issue":"8","key":"836_CR76","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1172\/JCI140183","volume":"130","author":"WC Song","year":"2020","unstructured":"Song WC, FitzGerald GA. COVID-19, microangiopathy, hemostatic activation, and complement. J Clin Invest. 2020;130(8):3950\u20133. https:\/\/doi.org\/10.1172\/JCI140183.","journal-title":"J Clin Invest"},{"issue":"1","key":"836_CR77","first-page":"976","volume":"8","author":"GD Sloop","year":"2021","unstructured":"Sloop GD, Pop GA, Weidman JJ, Cyr JA. The detrimental role of elevated blood viscosity in patients with COVID-19. Cardiol Ther. 2021;8(1):976\u201380.","journal-title":"Cardiol Ther"},{"issue":"10239","key":"836_CR78","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/S0140-6736(20)31209-5","volume":"395","author":"CL Maier","year":"2020","unstructured":"Maier CL, Truong AD, Auld SC, Polly DM, Tanksley CL, Duncan A. COVID-19-associated hyperviscosity: A link between inflammation and thrombophilia? Lancet. 2020;395(10239):1758\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(20)31209-5.","journal-title":"Lancet"},{"issue":"4","key":"836_CR79","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1778-428X.2007.00080.x","volume":"9","author":"C Lenz","year":"2008","unstructured":"Lenz C, Rebel A, Waschke KF, Koehler RC, Frietsch T. Blood viscosity modulates tissue perfusion\u2013sometimes and somewhere. Transfus Altern Transfus Med. 2008;9(4):265\u201372. https:\/\/doi.org\/10.1111\/j.1778-428X.2007.00080.x.","journal-title":"Transfus Altern Transfus Med"},{"issue":"1","key":"836_CR80","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12291-020-00935-0","volume":"36","author":"G Zubieta-Calleja","year":"2021","unstructured":"Zubieta-Calleja G, Zubieta-DeUrioste N. Pneumolysis and \u201dsilent hypoxemia\u201d in COVID-19. Indian J Clin Biochem. 2021;36(1):112\u20136. https:\/\/doi.org\/10.1007\/s12291-020-00935-0.","journal-title":"Indian J Clin Biochem"},{"key":"836_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117179","volume":"419","author":"T Wijeratne","year":"2020","unstructured":"Wijeratne T, Crewther S, Post C. Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community. J NeurolSci. 2020;419: 117179. https:\/\/doi.org\/10.1016\/j.jns.2020.117179.","journal-title":"J NeurolSci"},{"key":"836_CR82","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08848-3","author":"B Oronsky","year":"2021","unstructured":"Oronsky B, Larson C, Hammond TC, et al. A review of persistent post-COVID syndrome (PPCS). Clin Rev Allergy Immunol. 2021. https:\/\/doi.org\/10.1007\/s12016-021-08848-3.","journal-title":"Clin Rev Allergy Immunol"},{"key":"836_CR83","doi-asserted-by":"publisher","first-page":"100276","DOI":"10.1016\/j.ensci.2020.100276","volume":"21","author":"P Novak","year":"2020","unstructured":"Novak P. Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report. eNeurol Sci. 2020;21:100276. https:\/\/doi.org\/10.1016\/j.ensci.2020.100276.","journal-title":"eNeurol Sci"},{"issue":"5","key":"836_CR84","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","volume":"19","author":"T Le Thanh","year":"2020","unstructured":"Le Thanh T, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305\u20136. https:\/\/doi.org\/10.1038\/d41573-020-00073-5.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"836_CR85","doi-asserted-by":"publisher","first-page":"747","DOI":"10.4038\/sljch.v50i4.9908","volume":"50","author":"K Khon","year":"2021","unstructured":"Khon K, Mungmungpuntipantip R, Wiwanitkit V. Post COVID-19 vaccination, increased blood viscosity and impact on laboratory investigation results. Sri Lanka J Child Health. 2021;50(4):747. https:\/\/doi.org\/10.4038\/sljch.v50i4.9908.","journal-title":"Sri Lanka J Child Health"},{"issue":"2","key":"836_CR86","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1212\/wnl.44.2.223","volume":"44","author":"MC Dalakas","year":"1994","unstructured":"Dalakas MC. High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events. Neurology. 1994;44(2):223\u20136. https:\/\/doi.org\/10.1212\/wnl.44.2.223.","journal-title":"Neurology"},{"key":"836_CR87","first-page":"0","volume":"1","author":"S Yasri","year":"2021","unstructured":"Yasri S, Wiwanitkit V. COVID-19 vaccine, contraceptive, viscosity and safety margin change. Vaccine. 2021;1:0\u201392.","journal-title":"Vaccine"},{"issue":"7","key":"836_CR88","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.numecd.2008.11.005","volume":"19","author":"C Irace","year":"2009","unstructured":"Irace C, Scavelli F, Carallo C, Serra R, Gnasso A. Plasma and blood viscosity in metabolic syndrome. Nutr Metab Cardiovasc Dis. 2009;19(7):476\u201380. https:\/\/doi.org\/10.1016\/j.numecd.2008.11.005.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"836_CR89","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2217\/clp.12.65","volume":"7","author":"P Gyawali","year":"2012","unstructured":"Gyawali P, Richards RS, Nwose EU, Bwititi PT. Whole-blood viscosity and metabolic syndrome. Clin Lipidol. 2012;7(6):709\u201319. https:\/\/doi.org\/10.2217\/clp.12.65.","journal-title":"Clin Lipidol"},{"issue":"5","key":"836_CR90","first-page":"148","volume":"13","author":"B Joob","year":"2021","unstructured":"Joob B, Wiwanitkit V. Change of blood viscosity after COVID-19 vaccination: estimation for persons with underlying metabolic syndrome. IntJ Physiol Pathophysiol Pharmacol. 2021;13(5):148\u201351.","journal-title":"IntJ Physiol Pathophysiol Pharmacol"},{"issue":"27","key":"836_CR91","doi-asserted-by":"publisher","first-page":"10060","DOI":"10.1073\/pnas.0402937101","volume":"101","author":"DS Long","year":"2004","unstructured":"Long DS, Smith ML, Pries AR, Ley K, Damiano ER. Microviscometry reveals reduced blood viscosity and altered shear rate and shear stress profiles in microvessels after hemodilution. Proc Natl Acad Sci U S A. 2004;101(27):10060\u20135. https:\/\/doi.org\/10.1073\/pnas.0402937101.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"836_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.585354","volume":"11","author":"O Sharma","year":"2020","unstructured":"Sharma O, Sultan AA, Ding H, Triggle CR. A review of the progress and challenges of developing a vaccine for COVID-19. Front Immunol. 2020;11: 585354. https:\/\/doi.org\/10.3389\/fimmu.2020.585354.","journal-title":"Front Immunol"},{"key":"836_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2021.100525","volume":"24","author":"P Sookaromdee","year":"2021","unstructured":"Sookaromdee P, Wiwanitkit V. COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem. Ann Hepatol. 2021;24: 100525. https:\/\/doi.org\/10.1016\/j.aohep.2021.100525.","journal-title":"Ann Hepatol"},{"key":"836_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109022","volume":"179","author":"L D\u2019Onofrio","year":"2021","unstructured":"D\u2019Onofrio L, Coraggio L, Zurru A, et al. Short-term safety profile of Sars-Cov2 vaccination on glucose control: continuous glucose monitoring data in people with autoimmune diabetes. Diabetes Res Clin Pract. 2021;179: 109022. https:\/\/doi.org\/10.1016\/j.diabres.2021.109022.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"836_CR95","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1179\/1351000211Y.0000000017","volume":"17","author":"EU Nwose","year":"2012","unstructured":"Nwose EU, Richards RS, Bwititi P, Butkowski E. Serum bilirubin and lipoprotein-a: how are these associated with whole blood viscosity? Redox Rep. 2012;17(1):8\u201313. https:\/\/doi.org\/10.1179\/1351000211Y.0000000017.","journal-title":"Redox Rep"},{"issue":"12","key":"836_CR96","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1172\/JCI21625","volume":"114","author":"S Furukawa","year":"2004","unstructured":"Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752\u201361. https:\/\/doi.org\/10.1172\/JCI21625.","journal-title":"J Clin Invest"},{"issue":"4","key":"836_CR97","first-page":"309","volume":"37","author":"E Sol\u00e1","year":"2007","unstructured":"Sol\u00e1 E, Vay\u00e1 A, Sim\u00f3 M, et al. Fibrinogen, plasma viscosity and blood viscosity in obesity. Relationship with insulin resistance. Clin Hemorheol Microcirc. 2007;37(4):309\u201318.","journal-title":"Clin Hemorheol Microcirc"},{"issue":"2","key":"836_CR98","first-page":"119","volume":"1","author":"C Pivonello","year":"2021","unstructured":"Pivonello C, Negri M, Pivonello R, Colao A. How may obesity-induced oxidative stress affect the outcome of COVID-19 accines? Lesson Learn Infect Stresses. 2021;1(2):119\u201322.","journal-title":"Lesson Learn Infect Stresses."},{"issue":"36","key":"836_CR99","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1016\/j.vaccine.2015.06.101","volume":"33","author":"SD Painter","year":"2015","unstructured":"Painter SD, Ovsyannikova IG, Poland GA. The weight of obesity on the human immune response to vaccination. Vaccine. 2015;33(36):4422\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.101.","journal-title":"Vaccine"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00836-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-022-00836-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00836-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T14:08:58Z","timestamp":1687356538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-022-00836-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":99,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["836"],"URL":"https:\/\/doi.org\/10.1007\/s10238-022-00836-x","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,24]]},"assertion":[{"value":"15 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This article does not contain any studies with human or animal subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}